Shanxi Yangwenshui Pharmaceutical

Shanxi Yangwenshui Pharmaceutical is a Chinese pharmaceutical company primarily focused on the development and production of anti-cancer medications, particularly those derived from Traditional Chinese Medicine (TCM) research. The company is best known for its flagship product, the 'Yangwenshui Anti-Cancer Pill' (also known as 'Aifukang'), which is marketed for various solid tumors including liver, lung, and stomach cancers. Founded by Yang Wenshui, the company integrates traditional herbal knowledge with modern pharmaceutical manufacturing standards. Its operations include the cultivation of medicinal herbs, drug research and development, and large-scale production of capsules and pills. The company serves the domestic Chinese market with a focus on oncology and supportive care.